Oxytocin and Its Relationship to Body Composition, Bone Mineral Density, and Hip Geometry Across the Weight Spectrum
ContextOxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are co...
Saved in:
Published in | The journal of clinical endocrinology and metabolism Vol. 102; no. 8; pp. 2814 - 2824 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
Endocrine Society
01.08.2017
Copyright Oxford University Press Oxford University Press |
Subjects | |
Online Access | Get full text |
ISSN | 0021-972X 1945-7197 1945-7197 |
DOI | 10.1210/jc.2016-3963 |
Cover
Loading…
Abstract | ContextOxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown.ObjectiveTo determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum.DesignCross-sectional.SettingClinical research center.ParticipantsFifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19).Main Outcome MeasuresSerum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry.ResultsOXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant.ConclusionsThese data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment.Oxytocin levels are elevated in women with obesity compared with normal-weight women, are a marker of energy availability, and may be a mediator of bone density and strength across the weight spectrum. |
---|---|
AbstractList | Oxytocin levels are elevated in women with obesity compared with normal-weight women, are a marker of energy availability, and may be a mediator of bone density and strength across the weight spectrum. Abstract Oxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown. To determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum. Cross-sectional. Clinical research center. Fifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19). Serum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry. OXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant. These data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment. Oxytocin levels are elevated in women with obesity compared with normal-weight women, are a marker of energy availability, and may be a mediator of bone density and strength across the weight spectrum. Oxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown. To determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum. Cross-sectional. Clinical research center. Fifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19). Serum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry. OXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant. These data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment. Oxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown.ContextOxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown.To determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum.ObjectiveTo determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum.Cross-sectional.DesignCross-sectional.Clinical research center.SettingClinical research center.Fifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19).ParticipantsFifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19).Serum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry.Main Outcome MeasuresSerum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry.OXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant.ResultsOXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant.These data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment.ConclusionsThese data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment. ContextOxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown.ObjectiveTo determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum.DesignCross-sectional.SettingClinical research center.ParticipantsFifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19).Main Outcome MeasuresSerum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry.ResultsOXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant.ConclusionsThese data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment. ContextOxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown.ObjectiveTo determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum.DesignCross-sectional.SettingClinical research center.ParticipantsFifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19).Main Outcome MeasuresSerum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry.ResultsOXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant.ConclusionsThese data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment.Oxytocin levels are elevated in women with obesity compared with normal-weight women, are a marker of energy availability, and may be a mediator of bone density and strength across the weight spectrum. |
Author | Marengi, Dean A Lawson, Elizabeth A Pulumo, Reitumetse L Schorr, Melanie Miller, Karen K Eddy, Kamryn T Klibanski, Anne Yu, Elaine |
AuthorAffiliation | 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 2Harvard Medical School, Boston, Massachusetts 02115 3Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 4Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts 02114 |
AuthorAffiliation_xml | – name: 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 2Harvard Medical School, Boston, Massachusetts 02115 3Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 4Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts 02114 |
Author_xml | – sequence: 1 givenname: Melanie surname: Schorr fullname: Schorr, Melanie organization: 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 – sequence: 2 givenname: Dean A surname: Marengi fullname: Marengi, Dean A organization: 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 – sequence: 3 givenname: Reitumetse L surname: Pulumo fullname: Pulumo, Reitumetse L organization: 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 – sequence: 4 givenname: Elaine surname: Yu fullname: Yu, Elaine organization: 2Harvard Medical School, Boston, Massachusetts 02115 – sequence: 5 givenname: Kamryn T surname: Eddy fullname: Eddy, Kamryn T organization: 2Harvard Medical School, Boston, Massachusetts 02115 – sequence: 6 givenname: Anne surname: Klibanski fullname: Klibanski, Anne organization: 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 – sequence: 7 givenname: Karen K surname: Miller fullname: Miller, Karen K organization: 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 – sequence: 8 givenname: Elizabeth A surname: Lawson fullname: Lawson, Elizabeth A email: ealawson@partners.org organization: 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28586943$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kstv1DAQxiNURB9w44wscYDDpvgVPy5IZYG2UlElHoKb5U0mXS-JHWKHsv893t0WQaVysCyPf9_nmfEcFns-eCiKpwQfE0rwq1V9TDERJdOCPSgOiOZVKYmWe8UBxpSUWtJv-8VhjCuMCecVe1TsU1UpoTk7KNLlr3UKtfPI-gadp4g-QmeTCz4u3YBSQG9Cs0bz0A8huk18liMe0AfnYbQdegs-x9ezrf4sS04h9JDGNTqpxxAjSktAX8FdLRP6NECdxql_XDxsbRfhyc1-VHx5_-7z_Ky8uDw9n59clDWXGpdCCFyRugXMMZPQVKqlQlksGaegsaqtWrR20WSu5VLSZgFUWVZZgoVmGNhR8XrnO0yLHpoafMopm2F0vR3XJlhn_r3xbmmuwk9TVVyoimeDlzcGY_gxQUymd7GGrrMewhQN0Vji3FYiMvr8DroK0-hzeYYRwZnCgtP_UUQLrbWSmGTq2d95_0n49tsyQHfAtsUjtKZ2aftruQzXGYLNZjbMqjab2TCb2cii2R3Rre89ON_h16FLMMbv3XQNo1mC7dLS5KoxF1KVWSCxyqcyL4qz7MVOFqbhvge2s8p-A3BL1PQ |
CitedBy_id | crossref_primary_10_1016_j_neubiorev_2024_105765 crossref_primary_10_1007_s00223_021_00826_3 crossref_primary_10_3390_medicina58111625 crossref_primary_10_1186_s13148_022_01318_3 crossref_primary_10_1038_s41598_018_20963_4 crossref_primary_10_3390_brainsci13071075 crossref_primary_10_7570_jomes20098 crossref_primary_10_1093_braincomms_fcaa081 crossref_primary_10_3390_ijms24054832 crossref_primary_10_1016_j_clnu_2021_08_011 crossref_primary_10_1016_j_physbeh_2019_112684 crossref_primary_10_1111_cen_13909 crossref_primary_10_1111_dom_13527 crossref_primary_10_1111_obr_12757 crossref_primary_10_1159_000506638 crossref_primary_10_1038_s41366_018_0150_x crossref_primary_10_1016_j_npep_2023_102387 crossref_primary_10_1210_endrev_bnad033 crossref_primary_10_1016_j_cbpa_2024_111793 crossref_primary_10_1080_21678707_2018_1451326 crossref_primary_10_1210_jc_2019_00643 crossref_primary_10_1007_s11920_018_0957_0 crossref_primary_10_1159_000492001 crossref_primary_10_29252_rbmb_9_2_147 crossref_primary_10_1016_j_cpnec_2024_100242 crossref_primary_10_3389_fnins_2021_743546 crossref_primary_10_3390_ijms22147737 crossref_primary_10_1210_er_2018_00063 crossref_primary_10_1177_02698811241309617 crossref_primary_10_1016_j_physbeh_2024_114777 crossref_primary_10_1007_s40519_024_01698_w crossref_primary_10_1530_JOE_17_0680 crossref_primary_10_1007_s00213_019_05280_6 crossref_primary_10_1111_dom_15812 crossref_primary_10_1016_j_brainres_2017_09_024 crossref_primary_10_1016_j_pnpbp_2022_110561 crossref_primary_10_2174_0929867329666220727120646 crossref_primary_10_3389_fpsyt_2019_01032 crossref_primary_10_3389_fendo_2022_1049541 crossref_primary_10_1016_j_tem_2021_02_005 crossref_primary_10_1210_endrev_bnad025 crossref_primary_10_1111_jne_12805 crossref_primary_10_1093_ejendo_lvad087 crossref_primary_10_1210_endrev_bnz012 crossref_primary_10_1038_nrendo_2017_115 crossref_primary_10_3390_nu15163509 |
Cites_doi | 10.1210/jc.2014-2104 10.1055/s-0034-1395677 10.1016/0167-0115(87)90045-0 10.1210/jc.2009-1046 10.1111/j.1365-2265.2011.04182.x 10.4088/JCP.10m06617 10.1530/EJE-12-0869 10.1002/oby.20424 10.1210/jc.2013-3190 10.1152/ajpendo.00196.2011 10.1210/jc.2014-2206 10.1210/JC.2015-2078 10.1007/s00198-011-1578-1 10.1634/stemcells.2008-0127 10.1097/WNR.0b013e3283021ca9 10.1210/jc.2013-4126 10.1038/ncomms5082 10.1371/journal.pone.0025565 10.1016/j.jocd.2007.12.001 10.1152/ajpendo.00296.2011 10.1073/pnas.0901890106 10.1016/j.jbspin.2011.02.002 10.1007/BF03350119 10.1002/jbmr.506 10.1073/pnas.1523762113 10.1093/ajcn/51.6.1106 10.1002/oby.21069 10.1530/EJE-15-0875 10.1007/s00198-004-1820-1 10.1249/00005768-199301000-00010 10.1074/jbc.M112.365049 10.1016/0196-9781(91)90176-P 10.1359/jbmr.080802 10.1093/ajcn/37.2.311 10.1210/jc.2013-4136 10.1016/0196-9781(89)90082-X 10.1530/EJE-10-0523 10.1038/ijo.2016.149 |
ContentType | Journal Article |
Copyright | Copyright © 2017 Endocrine Society 2017 Copyright © Oxford University Press 2015 Copyright © 2017 Endocrine Society |
Copyright_xml | – notice: Copyright © 2017 Endocrine Society 2017 – notice: Copyright © Oxford University Press 2015 – notice: Copyright © 2017 Endocrine Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7T5 7TM 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1210/jc.2016-3963 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Immunology Abstracts Nucleic Acids Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Proquest Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1945-7197 |
EndPage | 2824 |
ExternalDocumentID | PMC5546854 28586943 10_1210_jc_2016_3963 00004678-201708000-00020 10.1210/jc.2016-3963 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: K24 HL092902 – fundername: NCRR NIH HHS grantid: UL1 RR025758 – fundername: NIDDK NIH HHS grantid: R01 DK052625 – fundername: NIDDK NIH HHS grantid: P30 DK040561 – fundername: NIDDK NIH HHS grantid: T32 DK007028 – fundername: NICHD NIH HHS grantid: K12 HD051959 – fundername: NIMH NIH HHS grantid: K23 MH092560 |
GroupedDBID | --- -~X .55 .GJ .XZ 08P 0R~ 18M 1TH 29K 2WC 34G 354 39C 3O- 3V. 4.4 48X 53G 5GY 5RS 5YH 7X7 88E 8F7 8FI 8FJ AABZA AACZT AAIMJ AAJQQ AAKAS AAPGJ AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWDT AAWTL AAYJJ ABBLC ABDFA ABDPE ABEJV ABGNP ABJNI ABLJU ABMNT ABNHQ ABOCM ABPMR ABPPZ ABPQP ABPTD ABQNK ABUWG ABVGC ABWST ABXVV ACFRR ACGFO ACGFS ACPRK ACUTJ ACYHN ACZBC ADBBV ADGKP ADGZP ADHKW ADQBN ADRTK ADVEK ADZCM AELWJ AEMDU AENEX AENZO AERZD AETBJ AEWNT AFCHL AFFNX AFFQV AFFZL AFGWE AFKRA AFOFC AFRAH AFXAL AFYAG AGINJ AGKRT AGMDO AGQXC AGUTN AHMBA AHMMS AI. AJEEA ALMA_UNASSIGNED_HOLDINGS APIBT APJGH AQDSO AQKUS ARIXL ASPBG ATGXG AVWKF AZFZN BAWUL BAYMD BCRHZ BENPR BEYMZ BPHCQ BSWAC BTRTY BVXVI C45 CCPQU CDBKE CS3 D-I DAKXR DIK E3Z EBS EIHJH EJD EMOBN ENERS F5P FECEO FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK FYUFA GAUVT GJXCC GX1 H13 HMCUK HVGLF HZ~ H~9 IAO IHR INH ITC J5H KBUDW KOP KQ8 KSI KSN L7B M1P M5~ MBLQV MHKGH MJL N4W N9A NLBLG NOMLY NOYVH NVLIB O9- OAUYM OBH OCB ODMLO OFXIZ OGEVE OHH OJZSN OK1 OPAEJ OVD OVIDX P2P P6G PQQKQ PROAC PSQYO REU ROX ROZ TEORI TJX TLC TMA TR2 TWZ UKHRP VH1 VVN W8F WHG WOQ X52 X7M YBU YFH YHG YOC YSK ZGI ZXP ZY1 ~02 ~H1 ABXZS ACVCV ADMTO ADNBA AEMQT AEOTA AGORE AHGBF AJBYB AJDVS ALXQX AVNTJ NU- OBFPC PHGZM PHGZT AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7T5 7TM 7XB 8FK H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c4790-666051cfe04037ed58f268a07342e908ca8bfabd666f4772dbe28a35a106930e3 |
IEDL.DBID | 7X7 |
ISSN | 0021-972X 1945-7197 |
IngestDate | Thu Aug 21 14:05:33 EDT 2025 Mon Jul 21 11:44:47 EDT 2025 Fri Jul 25 22:10:50 EDT 2025 Fri Jul 25 19:56:39 EDT 2025 Thu Apr 03 07:08:31 EDT 2025 Tue Jul 01 01:10:45 EDT 2025 Thu Apr 24 23:09:10 EDT 2025 Fri May 16 03:50:15 EDT 2025 Fri Feb 07 10:35:21 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
License | Copyright © 2017 Endocrine Society |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4790-666051cfe04037ed58f268a07342e908ca8bfabd666f4772dbe28a35a106930e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 28586943 |
PQID | 1969998701 |
PQPubID | 2046206 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5546854 proquest_miscellaneous_1907000116 proquest_journals_3164380642 proquest_journals_1969998701 pubmed_primary_28586943 crossref_citationtrail_10_1210_jc_2016_3963 crossref_primary_10_1210_jc_2016_3963 wolterskluwer_health_00004678-201708000-00020 oup_primary_10_1210_jc_2016-3963 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-August |
PublicationDateYYYYMMDD | 2017-08-01 |
PublicationDate_xml | – month: 08 year: 2017 text: 2017-August |
PublicationDecade | 2010 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States – name: Washington |
PublicationTitle | The journal of clinical endocrinology and metabolism |
PublicationTitleAlternate | J Clin Endocrinol Metab |
PublicationYear | 2017 |
Publisher | Endocrine Society Copyright Oxford University Press Oxford University Press |
Publisher_xml | – name: Endocrine Society – name: Copyright Oxford University Press – name: Oxford University Press |
References | ( key 20170807135912_B4) 2011; 3 ( key 20170807135912_B20) 2009; 106 ( key 20170807135912_B26) 2005; 16 ( key 20170807135912_B10) 1997; 423 ( key 20170807135912_B18) 2014; 99 ( key 20170807135912_B43) 2012; 27 ( key 20170807135912_B32) 2012; 76 ( key 20170807135912_B22) 2016; 113 ( key 20170807135912_B11) 2015; 23 ( key 20170807135912_B35) 1983; 64 ( key 20170807135912_B14) 2011; 72 ( key 20170807135912_B13) 2013 ( key 20170807135912_B31) 2011; 164 ( key 20170807135912_B29) 2014; 99 ( key 20170807135912_B30) 2009; 94 ( key 20170807135912_B36) 1983; 37 ( key 20170807135912_B27) 2008; 23 ( key 20170807135912_B44) 2013; 21 ( key 20170807135912_B19) 2008; 26 ( key 20170807135912_B40) 2008; 11 ( key 20170807135912_B1) 2008; 19 ( key 20170807135912_B16) 1989; 13 ( key 20170807135912_B3) 2012; 302 ( key 20170807135912_B8) 2011; 6 ( key 20170807135912_B12) 2016; 40 ( key 20170807135912_B21) 2012; 287 ( key 20170807135912_B34) 2016; 174 ( key 20170807135912_B38) 1990; 51 ( key 20170807135912_B41) 2015; 47 ( key 20170807135912_B28) 2014; 99 ( key 20170807135912_B17) 1988; 11 ( key 20170807135912_B23) 2007; 41 ( key 20170807135912_B33) 2015; 100 ( key 20170807135912_B7) 2011; 301 ( key 20170807135912_B24) 2011; 78 ( key 20170807135912_B5) 1989; 10 ( key 20170807135912_B25) 2013; 168 ( key 20170807135912_B39) 2012; 23 ( key 20170807135912_B2) 2014; 5 ( key 20170807135912_B9) 1987; 18 ( key 20170807135912_B37) 1993; 25 ( key 20170807135912_B42) 2014; 99 ( key 20170807135912_B6) 1991; 12 ( key 20170807135912_B15) 2014; 99 18257653 - Endocr Regul. 2007 Nov;41(4):131-41 2748428 - Peptides. 1989 Jan-Feb;10(1):89-93 19837921 - J Clin Endocrinol Metab. 2009 Dec;94(12):4710-6 21098684 - Eur J Endocrinol. 2011 Feb;164(2):253-61 18684092 - J Bone Miner Res. 2008 Dec;23(12):1892-904 19369205 - Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7149-54 24606095 - J Clin Endocrinol Metab. 2014 May;99(5):E881-5 26903591 - Eur J Endocrinol. 2016 Apr;174(4):503-12 24384013 - J Clin Endocrinol Metab. 2014 Jan;99(1):30-8 25565097 - Horm Metab Res. 2015 Jul;47(8):600-4 23258269 - Eur J Endocrinol. 2013 Feb 20;168(3):457-64 21394495 - Osteoporos Int. 2012 Feb;23(2):543-51 1646995 - Peptides. 1991 Jan-Feb;12(1):113-8 21915902 - J Bone Miner Res. 2012 Jan;27(1):119-24 18520999 - Neuroreport. 2008 Jun 11;19(9):951-5 23700406 - PLoS One. 2013 May 20;8(5):e61477 24915299 - Nat Commun. 2014 Jun 10;5:4082 2819958 - Regul Pept. 1987 Jul;18(1):7-18 23512706 - Obesity (Silver Spring). 2013 Dec;21(12):2458-64 22008455 - Am J Physiol Endocrinol Metab. 2012 Jan 1;302(1):E134-44 26171799 - J Clin Endocrinol Metab. 2015 Sep;100(9):3313-21 2349926 - Am J Clin Nutr. 1990 Jun;51(6):1106-12 18280192 - J Clin Densitom. 2008 Apr-Jun;11(2):232-6 25233153 - J Clin Endocrinol Metab. 2014 Dec;99(12):4683-9 22761429 - J Biol Chem. 2012 Aug 17;287(34):29159-67 6823895 - Am J Clin Nutr. 1983 Feb;37(2):311-4 21781144 - Clin Endocrinol (Oxf). 2012 Apr;76(4):520-5 6623350 - Stat Bull Metrop Life Found. 1983 Jan-Jun;64(1):3-9 25865294 - Obesity (Silver Spring). 2015 May;23(5):950-6 8423758 - Med Sci Sports Exerc. 1993 Jan;25(1):60-70 21980491 - PLoS One. 2011;6(9):e25565 25062461 - J Clin Endocrinol Metab. 2014 Dec;99(12):4664-73 21903023 - J Clin Psychiatry. 2011 Nov;72(11):1546-51 18583541 - Stem Cells. 2008 Sep;26(9):2399-407 22184277 - Aging (Albany NY). 2011 Dec;3(12):1169-77 26699482 - Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):164-9 24446658 - J Clin Endocrinol Metab. 2014 Apr;99(4):E634-41 3283208 - J Endocrinol Invest. 1988 Feb;11(2):125-8 21828335 - Am J Physiol Endocrinol Metab. 2011 Nov;301(5):E1004-12 21441053 - Joint Bone Spine. 2011 Dec;78(6):611-5 27553712 - Int J Obes (Lond). 2016 Nov;40(11):1707-1714 9401539 - Acta Paediatr Suppl. 1997 Nov;423:50-4 2744933 - Int J Obes. 1989;13(2):213-22 15688123 - Osteoporos Int. 2005 May;16(5):460-7 |
References_xml | – volume: 99 start-page: 4664 issue: 12 year: 2014 ident: key 20170807135912_B29 article-title: Comparison of hip geometry, strength, and estimated fracture risk in women with anorexia nervosa and overweight/obese women publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2014-2104 – volume: 47 start-page: 600 issue: 8 year: 2015 ident: key 20170807135912_B41 article-title: Differential regulation of oxytocin receptor in various adipose tissue depots and skeletal muscle types in obese Zucker rats publication-title: Horm Metab Res doi: 10.1055/s-0034-1395677 – volume: 18 start-page: 7 issue: 1 year: 1987 ident: key 20170807135912_B9 article-title: Binding and structural properties of oxytocin receptors in isolated rat epididymal adipocytes publication-title: Regul Pept doi: 10.1016/0167-0115(87)90045-0 – volume: 94 start-page: 4710 issue: 12 year: 2009 ident: key 20170807135912_B30 article-title: Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2009-1046 – volume: 76 start-page: 520 issue: 4 year: 2012 ident: key 20170807135912_B32 article-title: Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat publication-title: Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2011.04182.x – volume: 72 start-page: 1546 issue: 11 year: 2011 ident: key 20170807135912_B14 article-title: Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass publication-title: J Clin Psychiatry doi: 10.4088/JCP.10m06617 – volume: 168 start-page: 457 issue: 3 year: 2013 ident: key 20170807135912_B25 article-title: Nocturnal oxytocin secretion is lower in amenorrheic athletes than nonathletes and associated with bone microarchitecture and finite element analysis parameters publication-title: Eur J Endocrinol doi: 10.1530/EJE-12-0869 – volume: 21 start-page: 2458 issue: 12 year: 2013 ident: key 20170807135912_B44 article-title: Assessment of abdominal fat compartments using DXA in premenopausal women from anorexia nervosa to morbid obesity publication-title: Obesity (Silver Spring) doi: 10.1002/oby.20424 – volume: 99 start-page: 30 issue: 1 year: 2014 ident: key 20170807135912_B28 article-title: Association between lean mass, fat mass, and bone mineral density: a meta-analysis publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-3190 – volume: 301 start-page: E1004 issue: 5 year: 2011 ident: key 20170807135912_B7 article-title: Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin treatment publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00196.2011 – volume: 99 start-page: 4683 issue: 12 year: 2014 ident: key 20170807135912_B18 article-title: Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2 diabetic patients publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2014-2206 – volume: 100 start-page: 3313 issue: 9 year: 2015 ident: key 20170807135912_B33 article-title: Cortisol measures across the weight spectrum publication-title: J Clin Endocrinol Metab doi: 10.1210/JC.2015-2078 – volume: 423 start-page: 50 year: 1997 ident: key 20170807135912_B10 article-title: Prader-Willi syndrome and the hypothalamus publication-title: Acta Paediatr Suppl – volume: 13 start-page: 213 issue: 2 year: 1989 ident: key 20170807135912_B16 article-title: Elevated plasma levels of oxytocin in obese subjects before and after gastric banding publication-title: Int J Obes – volume: 23 start-page: 543 issue: 2 year: 2012 ident: key 20170807135912_B39 article-title: An in vivo comparison of hip structure analysis (HSA) with measurements obtained by QCT publication-title: Osteoporos Int doi: 10.1007/s00198-011-1578-1 – volume: 26 start-page: 2399 issue: 9 year: 2008 ident: key 20170807135912_B19 article-title: Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis publication-title: Stem Cells doi: 10.1634/stemcells.2008-0127 – volume: 19 start-page: 951 issue: 9 year: 2008 ident: key 20170807135912_B1 article-title: Oxytocin receptor-deficient mice developed late-onset obesity publication-title: Neuroreport doi: 10.1097/WNR.0b013e3283021ca9 – volume: 99 start-page: E634 issue: 4 year: 2014 ident: key 20170807135912_B42 article-title: Oxytocin, a new determinant of bone mineral density in post-menopausal women: analysis of the OPUS cohort publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-4126 – volume: 5 start-page: 4082 year: 2014 ident: key 20170807135912_B2 article-title: Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration publication-title: Nat Commun doi: 10.1038/ncomms5082 – volume: 6 start-page: e25565 issue: 9 year: 2011 ident: key 20170807135912_B8 article-title: Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats publication-title: PLoS One doi: 10.1371/journal.pone.0025565 – volume: 11 start-page: 232 issue: 2 year: 2008 ident: key 20170807135912_B40 article-title: Comparison of DXA hip structural analysis with volumetric QCT publication-title: J Clin Densitom doi: 10.1016/j.jocd.2007.12.001 – volume: 3 start-page: 1169 issue: 12 year: 2011 ident: key 20170807135912_B4 article-title: Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass publication-title: Aging (Albany NY) – volume: 302 start-page: E134 issue: 1 year: 2012 ident: key 20170807135912_B3 article-title: Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00296.2011 – volume: 106 start-page: 7149 issue: 17 year: 2009 ident: key 20170807135912_B20 article-title: Oxytocin is an anabolic bone hormone publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0901890106 – volume: 78 start-page: 611 issue: 6 year: 2011 ident: key 20170807135912_B24 article-title: Oxytocin and bone remodelling: relationships with neuropituitary hormones, bone status and body composition publication-title: Joint Bone Spine doi: 10.1016/j.jbspin.2011.02.002 – volume: 11 start-page: 125 issue: 2 year: 1988 ident: key 20170807135912_B17 article-title: Oxytocin response to insulin-induced hypoglycemia in obese subjects before and after weight loss publication-title: J Endocrinol Invest doi: 10.1007/BF03350119 – volume: 27 start-page: 119 issue: 1 year: 2012 ident: key 20170807135912_B43 article-title: Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT publication-title: J Bone Miner Res doi: 10.1002/jbmr.506 – volume: 113 start-page: 164 issue: 1 year: 2016 ident: key 20170807135912_B22 article-title: Functions of vasopressin and oxytocin in bone mass regulation publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1523762113 – volume: 51 start-page: 1106 issue: 6 year: 1990 ident: key 20170807135912_B38 article-title: Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition publication-title: Am J Clin Nutr doi: 10.1093/ajcn/51.6.1106 – volume: 23 start-page: 950 issue: 5 year: 2015 ident: key 20170807135912_B11 article-title: Oxytocin reduces caloric intake in men publication-title: Obesity (Silver Spring) doi: 10.1002/oby.21069 – volume: 174 start-page: 503 issue: 4 year: 2016 ident: key 20170807135912_B34 article-title: Leptin secretory dynamics and associated disordered eating psychopathology across the weight spectrum publication-title: Eur J Endocrinol doi: 10.1530/EJE-15-0875 – start-page: e61477 volume-title: PLoS One year: 2013 ident: key 20170807135912_B13 article-title: Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models – volume: 16 start-page: 460 issue: 5 year: 2005 ident: key 20170807135912_B26 article-title: Contributions of bone density and structure to fracture risk assessment in men and women publication-title: Osteoporos Int doi: 10.1007/s00198-004-1820-1 – volume: 41 start-page: 131 issue: 4 year: 2007 ident: key 20170807135912_B23 article-title: Possible neuroendocrine role for oxytocin in bone remodeling publication-title: Endocr Regul – volume: 64 start-page: 3 issue: 1 year: 1983 ident: key 20170807135912_B35 article-title: 1983 metropolitan height and weight tables publication-title: Stat Bull Metrop Life Found – volume: 25 start-page: 60 issue: 1 year: 1993 ident: key 20170807135912_B37 article-title: Measurement of physical activity to assess health effects in free-living populations publication-title: Med Sci Sports Exerc doi: 10.1249/00005768-199301000-00010 – volume: 287 start-page: 29159 issue: 34 year: 2012 ident: key 20170807135912_B21 article-title: Bone marrow oxytocin mediates the anabolic action of estrogen on the skeleton publication-title: J Biol Chem doi: 10.1074/jbc.M112.365049 – volume: 12 start-page: 113 issue: 1 year: 1991 ident: key 20170807135912_B6 article-title: Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats publication-title: Peptides doi: 10.1016/0196-9781(91)90176-P – volume: 23 start-page: 1892 issue: 12 year: 2008 ident: key 20170807135912_B27 article-title: Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures publication-title: J Bone Miner Res doi: 10.1359/jbmr.080802 – volume: 37 start-page: 311 issue: 2 year: 1983 ident: key 20170807135912_B36 article-title: Elbow breadth as a measure of frame size for US males and females publication-title: Am J Clin Nutr doi: 10.1093/ajcn/37.2.311 – volume: 99 start-page: E881 issue: 5 year: 2014 ident: key 20170807135912_B15 article-title: Oxytocin secretion is related to measures of energy homeostasis in young amenorrheic athletes publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-4136 – volume: 10 start-page: 89 issue: 1 year: 1989 ident: key 20170807135912_B5 article-title: Influence of oxytocin on feeding behavior in the rat publication-title: Peptides doi: 10.1016/0196-9781(89)90082-X – volume: 164 start-page: 253 issue: 2 year: 2011 ident: key 20170807135912_B31 article-title: Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index publication-title: Eur J Endocrinol doi: 10.1530/EJE-10-0523 – volume: 40 start-page: 1707 issue: 11 year: 2016 ident: key 20170807135912_B12 article-title: Oxytocin’s inhibitory effect on food intake is stronger in obese than normal-weight men publication-title: Int J Obes doi: 10.1038/ijo.2016.149 – reference: 2349926 - Am J Clin Nutr. 1990 Jun;51(6):1106-12 – reference: 3283208 - J Endocrinol Invest. 1988 Feb;11(2):125-8 – reference: 26903591 - Eur J Endocrinol. 2016 Apr;174(4):503-12 – reference: 24384013 - J Clin Endocrinol Metab. 2014 Jan;99(1):30-8 – reference: 6623350 - Stat Bull Metrop Life Found. 1983 Jan-Jun;64(1):3-9 – reference: 2819958 - Regul Pept. 1987 Jul;18(1):7-18 – reference: 25233153 - J Clin Endocrinol Metab. 2014 Dec;99(12):4683-9 – reference: 24446658 - J Clin Endocrinol Metab. 2014 Apr;99(4):E634-41 – reference: 18520999 - Neuroreport. 2008 Jun 11;19(9):951-5 – reference: 22761429 - J Biol Chem. 2012 Aug 17;287(34):29159-67 – reference: 23512706 - Obesity (Silver Spring). 2013 Dec;21(12):2458-64 – reference: 19837921 - J Clin Endocrinol Metab. 2009 Dec;94(12):4710-6 – reference: 22184277 - Aging (Albany NY). 2011 Dec;3(12):1169-77 – reference: 26171799 - J Clin Endocrinol Metab. 2015 Sep;100(9):3313-21 – reference: 21394495 - Osteoporos Int. 2012 Feb;23(2):543-51 – reference: 26699482 - Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):164-9 – reference: 23258269 - Eur J Endocrinol. 2013 Feb 20;168(3):457-64 – reference: 2748428 - Peptides. 1989 Jan-Feb;10(1):89-93 – reference: 21903023 - J Clin Psychiatry. 2011 Nov;72(11):1546-51 – reference: 18684092 - J Bone Miner Res. 2008 Dec;23(12):1892-904 – reference: 25565097 - Horm Metab Res. 2015 Jul;47(8):600-4 – reference: 21781144 - Clin Endocrinol (Oxf). 2012 Apr;76(4):520-5 – reference: 21828335 - Am J Physiol Endocrinol Metab. 2011 Nov;301(5):E1004-12 – reference: 25865294 - Obesity (Silver Spring). 2015 May;23(5):950-6 – reference: 21441053 - Joint Bone Spine. 2011 Dec;78(6):611-5 – reference: 21098684 - Eur J Endocrinol. 2011 Feb;164(2):253-61 – reference: 25062461 - J Clin Endocrinol Metab. 2014 Dec;99(12):4664-73 – reference: 18257653 - Endocr Regul. 2007 Nov;41(4):131-41 – reference: 21915902 - J Bone Miner Res. 2012 Jan;27(1):119-24 – reference: 19369205 - Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7149-54 – reference: 22008455 - Am J Physiol Endocrinol Metab. 2012 Jan 1;302(1):E134-44 – reference: 24606095 - J Clin Endocrinol Metab. 2014 May;99(5):E881-5 – reference: 18583541 - Stem Cells. 2008 Sep;26(9):2399-407 – reference: 24915299 - Nat Commun. 2014 Jun 10;5:4082 – reference: 27553712 - Int J Obes (Lond). 2016 Nov;40(11):1707-1714 – reference: 1646995 - Peptides. 1991 Jan-Feb;12(1):113-8 – reference: 15688123 - Osteoporos Int. 2005 May;16(5):460-7 – reference: 8423758 - Med Sci Sports Exerc. 1993 Jan;25(1):60-70 – reference: 18280192 - J Clin Densitom. 2008 Apr-Jun;11(2):232-6 – reference: 9401539 - Acta Paediatr Suppl. 1997 Nov;423:50-4 – reference: 2744933 - Int J Obes. 1989;13(2):213-22 – reference: 21980491 - PLoS One. 2011;6(9):e25565 – reference: 6823895 - Am J Clin Nutr. 1983 Feb;37(2):311-4 – reference: 23700406 - PLoS One. 2013 May 20;8(5):e61477 |
SSID | ssj0014453 |
Score | 2.446868 |
Snippet | ContextOxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia... Oxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa... Abstract Oxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia... Oxytocin levels are elevated in women with obesity compared with normal-weight women, are a marker of energy availability, and may be a mediator of bone... |
SourceID | pubmedcentral proquest pubmed crossref wolterskluwer oup |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2814 |
SubjectTerms | Absorptiometry Absorptiometry, Photon Adult Anorexia Anorexia Nervosa - metabolism Body Composition Body Mass Index Body weight Bone composition Bone Density Bone mineral density Clinical s Cross-Sectional Studies Dual energy X-ray absorptiometry Eating disorders Energy Female Geometry Hip Hip - diagnostic imaging Hormones Humans Hypothalamus Intra-Abdominal Fat - diagnostic imaging Obesity Obesity - metabolism Osteoporosis Overweight Oxytocin Oxytocin - metabolism Spine Spine - diagnostic imaging Subcutaneous Fat - diagnostic imaging Weight Young Adult |
Title | Oxytocin and Its Relationship to Body Composition, Bone Mineral Density, and Hip Geometry Across the Weight Spectrum |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-201708000-00020 https://www.ncbi.nlm.nih.gov/pubmed/28586943 https://www.proquest.com/docview/1969998701 https://www.proquest.com/docview/3164380642 https://www.proquest.com/docview/1907000116 https://pubmed.ncbi.nlm.nih.gov/PMC5546854 |
Volume | 102 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgkxASQnyOwJiMBE_MIont2HlCG2wUpA6EmOhb5MSO1sGSsmaC_vfcOW5YBOO1PqdJ7iP38_18JuS5kbwWlbYsyRQAlNTGzNR5xgSPra0Vl9bv4p8eZZNj8WEmZ2HBbRloleuY6AO1bStcI3-FbVwAGqg4eb34wfDUKKyuhiM0rpNNbF2GlC41GwAXYIXQhRJpCCqdBeI77lo5xfaFScZ4nvHRJ2m0ze1Stvk3afLWzxYL2stvns9-6at0eIfcDukk3ev1f5dcc809cmMaCub3Sffx16qD999Q01j6vlvSgf12Ml_QrqX7rV1RjAqBvbULvzSOTue-HTV9iwT3brXr509gyjvXnrnufEX3_NNQSCDpV7--SvEs--784uwBOT48-PJmwsJBC6wSKgf4mAGoSaragUdz5azUdZppA94vUpfHujK6rE1pQa4WkI7b0qXacGkAT-Y8dvwh2Wjg3h4Rah1cy9hSZioV0qhccyuFqiFLMq5KbURert91UYUu5HgYxvcC0QhopjitCtRMgZqJyItBetF337hCjoLarhJhvcj2WqdFcNNl8ceo_jnMAUtyjRAtIs-GYfA_LKqYxrUXeAkImr6cFZGt3kKG-0i11Fku4L_VyHYGAeztPR5p5ie-xzeSB7UUEWEjKyv63bGFh3aQZ0CQSxQm_b49QBo__v9TPiE3cUJPYNwmG2AT7ikkVV254z1nh2zuHxx9-vwbsO8eFg |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwELZGJ8EkhPg5CgOMxJ5YRGo7sfOA0MY2WrYWBJvoW3BiR-tgSVkzjfxT_I3cOWlYBeNtr_XZTXLny325786EvNABz0SqjNcLJQAUZnxPZ1HoCe4bk0keGFfFPxyF_UPxfhyMl8iveS0M0irnPtE5alOk-I38FbZxAWgg_d6b6Q8PT43C7Or8CI3aLPZsdQ6QbfZ6sA36XWdsd-fgbd9rThXwUiEjwEohRPC9NLNgvlxaE6iMhUqDqQtmI1-lWiWZTgzIZQJiT5NYpjQPNICniPuWw7rXyLLgAGU6ZHlrZ_TxU5u3EKLpe4nEB8nGDdUe62SOsWFiL_R4FPKFl-BCYd2F-PZvmubN8wJT6LNvjkF_4T24e5vcagJYullb3B2yZPO75PqwSdHfI-WHn1UJGs-pzg0dlDPa8u2OJlNaFnSrMBVFP9TwxTbgl9zS4cQ1wKbbSKkvqw03vw9T3tnixJanFd10d0MhZKVf3Bdd-hnrRE_PTu6TwytRwgPSyeHaHhJqLKylTRKEkolAy0hxEwiZQVymbcpMl7ycP-s4bfqe4_Eb32PEP6CZ-DiNUTMxaqZL1lvpad3v4xI5Cmq7TMSrRdbmOo0bxzCL_5jxP4c5oFeuEBR2yfN2GHY8pnF0boszXALctEugdclqbSHtdTAVqDAS8N9ywXZaAewmvjiST45cV3GkK6pAdIm3YGVxXY8bOzAJkQ241Z5EmOEaEjD_0f_v8hm50T8Y7sf7g9HeY7KCk2v65BrpgH3YJxDSlcnTZh9R8vWqt-5vA5xZSQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oxytocin+and+Its+Relationship+to+Body+Composition%2C+Bone+Mineral+Density%2C+and+Hip+Geometry+Across+the+Weight+Spectrum&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Schorr%2C+Melanie&rft.au=Marengi%2C+Dean+A.&rft.au=Pulumo%2C+Reitumetse+L.&rft.au=Yu%2C+Elaine&rft.date=2017-08-01&rft.pub=Endocrine+Society&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=102&rft.issue=8&rft.spage=2814&rft.epage=2824&rft_id=info:doi/10.1210%2Fjc.2016-3963&rft_id=info%3Apmid%2F28586943&rft.externalDocID=PMC5546854 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon |